Literature DB >> 21647122

Market overlap points to irresponsible use of tuberculosis drugs.

Erika Check-Hayden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21647122     DOI： 10.1038/nm0611-635

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Size and usage patterns of private TB drug markets in the high burden countries.

Authors:  William A Wells; Colin Fan Ge; Nitin Patel; Teresa Oh; Elizabeth Gardiner; Michael E Kimerling
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240
  1 in total
  1 in total

1.  Drug-resistant tuberculosis: emerging treatment options.

Authors:  Meghna Adhvaryu; Bhasker Vakharia
Journal:  Clin Pharmacol       Date:  2011-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.